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SocietyOsteoarthritis has a strong genetic component and family
based studies have indicated that heritability of the disease
ranges between 40% and 80% depending on the site af-
fected and the characteristics of the population being stud-
ied1,2. Although genetic factors clearly contribute to the
pathogenesis of osteoarthritis, we are still a long way from
understanding how genes and environment interact to
cause this common and disabling disease.
So far, two main approaches have been used to try and
identify the genetic variants that predispose to osteoarthri-
tis; genome wide linkage analysis in families and candidate
gene association studies in unrelated individuals. Family
based linkage studies have identiﬁed several candidate
loci that potentially harbour genes which predispose to os-
teoarthritis, but with some exceptions3 the regions so far
identiﬁed by these studies have failed to reach the logarithm
of the odds score thresholds required for genome wide
signiﬁcance4e7. Nonetheless, analysis of candidate genes
from some of these loci has resulted in the identiﬁcation
of variants that appear to predispose to osteoarthritis.
One example is MATN3 which is a candidate gene that
lies within a locus on chromosome 2 that was linked to
hand osteoarthritis in the Icelandic population3. The
MATN3 gene encodes matrilin-3, a component of extracel-
lular matrix, and mutation screening of this gene identiﬁed
a protein coding polymorphism which was found to segre-
gate with hand osteoarthritis in Icelandic families3. Subse-
quently, the same polymorphism was reported to be
associated with osteoarthritis in other populations8, support-
ing the hypothesis that MATN3 is a true susceptibility gene
for osteoarthritis. Further proof of the importance of MATN3
in the pathogenesis of osteoarthritis came from the recent
observation that targeted inactivation of MATN3 causes
premature osteoarthritis in mice and a generalised increase
in bone density9. This phenotype is of special interest since
increases in bone density are well known to be associated
with osteoarthritis in humans10, thereby raising the possibil-
ity that some genetic variants which predispose to osteoar-
thritis might protect against osteoporosis and vice versa.
Another example is the FRZB gene which maps to within
a weak candidate locus for hip osteoarthritis that was orig-
inally identiﬁed on chromosome 2q23 by linkage analysis11.
The FRZB gene encodes frizzled related protein 3, an an-
tagonist of wnt signalling and mutation screening of this
gene identiﬁed a coding polymorphism at position 324
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which was associated with osteoarthritis in the families orig-
inally used to identify linkage as well as additional families
and a case control study of unrelated subjects12. Functional
studies suggest that the osteoarthritis associated glycine
variant has diminished ability to antagonise wnt signalling
thereby raising the possibility that activation of wnt signal-
ling could play a role in the pathogenesis of osteoarthritis.
Candidate gene association studies have resulted in the
identiﬁcation of several variants that could potentially pre-
dispose to osteoarthritis including the oestrogen receptor
alpha (ESR1) gene13, and the Calmodulin-1 gene14. There
is evidence that genetic variants within the interleukin-1
cluster both predispose to osteoarthritis and are involved
in disease progression15. Although some of these associa-
tions have been replicated in different populations16, others
have not, even with adequately powered studies17. It is un-
clear to what extent failure to replicate association studies in
different populations represent true differences in alleles
that predispose to osteoarthritis across ethnic groups; pop-
ulation-speciﬁc differences in environmental factors that
interact with these variants; or false positive results. There
is considerable controversy on whether or not ethic differ-
ences in genetic effects for complex disease truly exist18
and it could be that some instances of failure to conﬁrm as-
sociations are due to unrealistically high estimates of the
genetic risk in the initial ‘‘positive’’ study19. It is certainly
clear that few of the genetic associations which have
been described in osteoarthritis have been validated by
really large scale studies, such as those that have started
to emerge in other areas of musculoskeletal genetics20,21.
Indeed, most of the genetic studies performed so far in
the osteoarthritis ﬁeld have been underpowered to detect
the modest effects expected for polygenic inﬂuences on
this complex disease.
In the current issue of Osteoarthritis and Cartilage, Kraus
and colleagues22 describe the characteristics of a large fam-
ily based study (the Genetics of Generalised Osteoarthritis
or ‘‘GOGO’’ study) involving 2706 subjects from 707 kin-
dreds who were selected on the basis that two or more rela-
tives had clinical evidence of hand osteoarthritis. Although
osteoarthritis of the hand has less of an impact on morbidity
than osteoarthritis of the hip or knee, many affected subjects
in GOGO also had radiological osteoarthritis at other sites
including the spine (54%), the knee (51%) and the hip
(25%). In view of this, it is probable that GOGO will provide
a resource for mapping genes that predispose not only to
hand osteoarthritis, but also to osteoarthritis of other joints.
The GOGO population is the largest family based cohort
study of osteoarthritis assembled so far and represents an17
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genes for the disease. But is the study big enough to iden-
tify novel genes that regulate susceptibility to osteoarthritis?
Power calculations performed by the authors indicate that
GOGO has good power to detect linkage to a locus that
doubles the risk of hand osteoarthritis assuming that a single
locus is involved in at least 20% of the study population.
Whilst the genetic architecture of osteoarthritis is poorly un-
derstood, the studies that have so far been performed indi-
cate that the susceptibility genes act in a site speciﬁc and
gender speciﬁc manner11 and this will limit the power that
GOGO has to detect genes that regulate susceptibility to
osteoarthritis at other sites. Even accounting for this how-
ever, GOGO compares favourably in terms of sample size
with family based cohorts that have selected for involve-
ment of major joints such as the knee and hip4,7,23 and
with modern genetic mapping techniques such as using
dense single nucleotide polymorphism maps for linkage24
and genome wide association25, the power may actually
be better than originally estimated.
The clinical importance of identifying genetic determi-
nants of susceptibility to osteoarthritis is to improve un-
derstanding of pathophysiology; to develop new markers
for progressive disease and perhaps most importantly,
to identify signalling pathways that can act as a target
for the development of new treatments. The GOGO co-
hort will be of value in furthering some of these aims
and this was undoubtedly an important motivation for
GlaxoSmithKline e the pharmaceutical company that
funded collection of the GOGO cohort. The pharmaceuti-
cal industry has also become involved in funding the col-
lection of other large cohorts of patients with osteoarthritis
in collaboration with publicly funded bodies. In the USA
for example, the National Institute of Arthritis and Muscu-
loskeletal and Skin Diseases (NIAMS) has joined forces
with several pharmaceutical companies to collect longitu-
dinal information on clinical, radiological and biomarker
based determinants of progression of knee osteoarthritis
in over 5000 subjects within the osteoarthritis initiative
(OAI) (http://www.nih.gov/news/pr/aug2006/niams-01.htm).
The OIA project will provide a very valuable resource to
investigate the genetic epidemiology of knee osteoarthritis
and would help to answer the question as to whether or
not the genetic variants that predispose to osteoarthritis
overlap with those that mediate disease progression. It
is to be hoped that the NIAMS initiative, coupled with
the lead provided by GOGO will also provide an impetus
for funding bodies in Europe and elsewhere, to assemble
large intensively phenotyped cohorts of patients with
osteoarthritis so that we can continue to make progress
in understanding the pathogenesis of this common dis-
abling disease.
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